ARTICLE | Company News
Amgen, Array BioPharma deal
July 23, 2012 7:00 AM UTC
Array received an $8.5 million milestone payment from Amgen under a 2009 deal granting Amgen exclusive, worldwide rights to develop and commercialize Array's small molecule glucokinase activator (GKA...